PR Newswire: news distribution, targeting and monitoring
2014

Epizyme to Present at Upcoming Scientific and Financial Conferences in October

Share with Twitter Share with LinkedIn

CAMBRIDGE, Mass., Sept. 28, 2012 /PRNewswire/ -- Epizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, today announced its participation in three upcoming conferences.

"With a focused approach on personalized therapeutics for genetically defined cancers, Epizyme is excited to present the foundations of our clinical platform and share this information with both the scientific community and investors," said Jason Rhodes, Executive Vice President and Chief Business Officer, Epizyme.

About Epizyme
Epizyme is leading the creation of small molecule histone methyltransferase inhibitors (HMTi), a new class of personalized therapeutics for patients with genetically defined cancers.  Genetic alterations in HMTs, a family of epigenetic enzymes, drive multiple human diseases.  Our approach represents the future of healthcare by matching better medicines with the right patients.

Epizyme has benchmark partnerships with Celgene, GSK and Eisai and receives funding and strategic support from the Multiple Myeloma Research Foundation (MMRF) and the Leukemia & Lymphoma Society (LLS). For more information, visit www.epizyme.com.

Media Contact
Amanda Sellers
Spectrum
202.955.6222 x 2597
asellers@spectrumscience.com

SOURCE Epizyme, Inc.



RELATED LINKS
http://www.epizyme.com

Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 
Area to test

Online Member Center

Not a Member?
Click Here to Join
Login
Search News Releases
Advanced Search
Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release